Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Elecsys® PIVKA-II
Elecsys® PIVKA-II
Pivka-II Monoclonal Antibody (DCP tumor marker) - China Pivka-II, Antibody | Made-in-China.com
Levels of AFP and PIVKA-II in Different Types of Liver Diseases A B | Download Scientific Diagram
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Medicina | Free Full-Text | Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients
Frontiers | Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Premium Photo | Pivka ii or protein induced by vitamin k ii test a screening marker for hepatocellular carcinoma
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
pivka_ii_pair_recommendations_1.jpg
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Evaluation of Diagnostic Utility of Protein Induced by Vitamin K Absence–II (PIVKA-II) in Hepatocellular Carcinoma
The Relationship between Serum PIVKA-II Levels and the Severity of... | Download Table
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma | PLOS ONE
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma - Clinical Laboratory int.
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - Journal of Clinical Laboratory Analysis - Wiley Online Library
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
